No increase of beta 2-glycoprotein i levels in patients with antiphospholipid antibodies
De Benedetti, E.; Reber, G.; Miescher, P.A.; de Moerloose, P.
Thrombosis and Haemostasis 68(5): 624
1992
ISSN/ISBN: 0340-6245 PMID: 1455413 Document Number: 389151
Document emailed within 1 workday
Related Documents
Alarcon-Segovia, D.; Mestanza, M.; Cabiedes, J.; Cabral, A.R. 1997: The antiphospholipid/cofactor syndromes. II. a variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein i but no antibodies detectable in standard antiphospholipid assays Journal of Rheumatology 24(8): 1545-1551Oosting, J.D.; Derksen, R.H.; Hackeng, T.M.; van Vliet, M.; Preissner, K.T.; Bouma, B.N.; de Groot, P.G. 1991: In vitro studies of antiphospholipid antibodies and its cofactor, beta 2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation Thrombosis and Haemostasis 66(6): 666-671
Tinahones, F.J.; Cuadrado, M.J.; Khamashta, M.A.; Mujic, F.; Gomez-Zumaquero, J.M.; Collantes, E.; Hughes, G.R. 1998: Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome British Journal of Rheumatology 37(7): 746-749
Previtali, S.; Barbui, T.; Galli, M. 2002: Anti-beta2-glycoprotein i and anti-prothrombin antibodies in antiphospholipid-negative patients with thrombosis: a case control study Thrombosis and Haemostasis 88(5): 729-732
Donohoe, S.; Kingdom, J.C.; Mackie, I.J.; Burrell, S.; Quenby, S.; Jauniaux, E.; Machin, S.J. 2000: Ontogeny of beta 2 glycoprotein i and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies Thrombosis and Haemostasis 84(1): 32-38
Latalska, M.łg.; Gerkowicz, M.; Kosior-Jarecka, E.; Kozioł-Montewka, M.; Pietraś-Trzpiel, M.łg. 2004: Antibodies to beta-2 glycoprotein i in serum and aqueous humor of patients with glaucoma and their influence on the static perimetry Klinika Oczna 106(1-2(Suppl): 160-161
Forastiero, R.R.; Kordich, L.; Basilotta, E.; Carreras, L.O. 1994: Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 5(4): 609-616
Palareti, G.; Legnani, C.; Ludovici, S.; Boggian, O.; Coccheri, S. 1991: Prevalence of high levels of antiphospholipid antibodies in otherwise unexplained juvenile venous thromboembolism Thrombosis and Haemostasis 65(4): 452-453
Amengual, O.; Atsumi, T.; Khamashta, M.A.; Hughes, G.R. 1996: Clinical significance of anti-beta 2-glycoprotein i antibodies Annales de Medecine Interne 147(Suppl 1): 15-17
Izumi, T.; Pound, M.L.; Su, Z.; Iverson, G.M.; Ortel, T.L. 2002: Anti-beta(2)-glycoprotein i antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein i to phospholipids Thrombosis and Haemostasis 88(4): 620-626
Arvieux, J.; Roussel, B.; Pouzol, P.; Colomb, M.G. 1993: Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein i Thrombosis and Haemostasis 70(2): 336-341
Bregani, E.R.; Corneo, G.; Pogliani, E.M. 1992: Antiphospholipid antibodies and splenic thrombosis in a patient with idiopathic myelofibrosis (antiphospholipid antibodies and thrombosis) Haematologica 77(6): 516-517
Arnout, J.; Vanrusselt, M.; Wittevrongel, C.; Vermylen, J. 1998: Monoclonal antibodies against beta-2-glycoprotein I: use as reference material for lupus anticoagulant tests Thrombosis and Haemostasis 79(5): 955-958
Sciarra, A.; Stasi, R.; Stipa, E.; Masi, M.; Oliva, F.; Olivieri, M.; Perrotti, A.; Zaccari, G.; Amadori, S.; Papa, G. 1995: Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma Recenti Progressi in Medicina 86(2): 57-62
Stasi, R.; Stipa, E.; Masi, M.; Oliva, F.; Sciarra, A.; Perrotti, A.; Zaccari, G.; Papa, G. 1993: Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma Thrombosis and Haemostasis 70(4): 568-572
Shi, W.; Chong, B.H.; Hogg, P.J.; Chesterman, C.N. 1993: Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein i of the factor Xa generating activity of platelets Thrombosis and Haemostasis 70(2): 342-345
Boffa, M.C.; Piette, J.C. 1996: Questions-answers about antiphospholipid-protein antibodies and the "antiphospholipid antibody syndrome" Annales de Medecine Interne 147 Suppl. 1: 54-56
Kühne, C.; Keitel, W.; Flach, W. 1994: Clinical relevance of the antiphospholipid syndrome. Antiphospholipid antibodies in a mixed rheumatologic patient sample Fortschritte der Medizin 112(30): 423-426
Cabiedes, J.; Cabral, A.R.; Alarcón-Segovia, D. 1993: Detection of anticardiolipin antibodies in heat-inactivated normal human sera is not influenced by beta 2-glycoprotein-I Thrombosis Research 72(5): 471-472
Miyoshi, Y. 2001: Expression of beta 2 glycoprotein I, the major target antigen for anti-cardiolipin antibodies, in human endothelium Hokkaido Journal of Medical Science 76(5): 289-298